Effect and prognosis of peri- pancreatic stepwise minimally invasive treatment in patients with severe acute pancreatitis

Xiong Yong; Wang HeBin; Liu DeQin; Chen JianXun; Liu JianPing; Sun ChangQin

doi:10.3969/j.issn.1001-5256.2016.03.029

Issue 3

Mar. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(3): 533-536

PDF( 1525 KB)

Effect and prognosis of peri- pancreatic stepwise minimally invasive treatment in patients with severe acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2016.03.029

Department of Hepatobiliary Surgery, Panzhihua Central Hospital

Published Date: 2016-03-20

Abstract

Abstract

Objective To investigate the clinical effect and prognosis of peri- pancreatic stepwise minimally invasive treatment in patients with severe acute pancreatitis( SAP). Methods The clinical data of 110 patients with SAP who were treated in Panzhihua Central Hospital from January 2013 to December 2014 were analyzed retrospectively,and these patients were divided into two groups( 55 patients in each group) according to the treatment regimen. The patients in the control group were treated with laparotomy,and those in the study group received peri- pancreatic stepwise minimally invasive treatment. The postoperative short- term treatment outcome,Acute Physiology and Chronic Health Evaluation Ⅱ( APACHE Ⅱ) score,laboratory markers [serum amylase( AMS),white blood cell( WBC),and C- reactive protein( CRP) ],time to intestinal recovery,incidence of complications,and mortality were compared between the two groups. The t- test was applied for comparison of continuous data between the two groups,and the chi- square test was applied for comparison of categorical data between the two groups. Results Compared with the control group,the study group had significantly higher short- term marked response rate,response rate,and overall response rate( χ2= 5. 1665,4. 9865 and 5. 6357,all P < 0. 05). There were significant differences in AMS,WBC,pulse oxygen saturation( Sp O2),CRP,and APACHE Ⅱ score between the two groups at 1 week after surgery and at discharge( t =13. 6585,13. 4698,12. 0566,14. 6856,and 13. 8869 for 1 week after surgery,t = 12. 8946,14. 2683,13. 8963,14. 8989,and 13. 0986 for discharge,all P < 0. 05); there was a significant difference in WBC count on day 1 after surgery between the two groups( χ2= 12. 6984,P < 0. 05); both groups showed significant improvements in AMS,WBC,Sp O2,CRP,and APACHE Ⅱ score at 1 week after surgery and at discharge compared with the values on day 1 after surgery,and there were significant changes in these values within each group( all P <0. 05); compared with the control group,the study group had a significantly shorter time to intestinal recovery,a significantly lower mortality rate,and a significantly lower incidence of complications( pleural effusion,dyspnea,false- positive cysts,and wound infection)( t = 13. 6985,P = 0. 042,χ2= 8. 3968,5. 6357,4. 0673,4. 0371,and 4. 4071,all P < 0. 05). Conclusion Peri- pancreatic stepwise minimally invasive treatment has a significant effect in the treatment of SAP and can improve the prognosis of patients. Therefore,it holds promise for clinical application.
- pancreatitis,
- surgical procedures,minimally invasuve,
- treatment outcome

FullText(HTML)

References(17)

References

[1]SUN GW,PENG KX.Advances in surgical intervention of severe acute pancreatitis[J].J Regional Anatomy Operative Surg,2012,21(6):662-664.(in Chinese)孙广伟,彭克学.重症急性胰腺炎外科干预研究进展[J].局解手术学杂志,2012,21(6):662-664.

[2]PIAO MY,SONG LJ.One infantile case of severe acute pancreatitis[J].J Clin Hepatol,2013,29(6):464-465.(in Chinese)朴美英,宋丽君.幼儿急性重症胰腺炎1例报告[J].临床肝胆病杂志,2013,29(6):464-465.

[3] Pancreas Study Group,Chinese Society of Gastroent,Editorial Board of Chinese Journal of Pancreatolog,Editorial Board of Chinese Journal of Digestion.Chinese guidelines for the management of acute pancreatitis(Shanghai,2013)[J].J Clin Hepatol,2013,29(9):656-660.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南(2013年,上海)[J].临床肝胆病杂志,2013,29(9):656-660.

[4]HARPER SJ,CHESLYN-CURTIS S.Acute pancreatitis[J].Ann Clin Biochem,2011,48(Pt 1):23-37.

[5]BESSELINK MG,van SANTVOORT HC,BAKKER OJ,et al.Draining sterile flued collections in acute pancreatitis primum non nocere[J].Surg Endosc,2011,25(1):331-332.

[6]MA ZF,WANG RR,SONG ZJ.Emergency medicine[M].Beijing:Military Medical Science Press,2007:504-505.(in Chinese)马中富,王瑞儒,宋祖军.急诊医学[M].北京:军事医学科学出版社,2007:504-505.

[7]ZOU JY,LIN J,YI SF,et al.Comparison of BISAP,Ranson's,APACHEⅡand CTSI scores in evaluating the severity of acute pancreatitis[J].Chin J Digest Surg,2014,13(1):39-41.(in Chinese)邹金艳,林军,易三凤,等.BISAP、Ranson's、APACHEⅡ和CTSI评分系统在急性胰腺炎评估中的价值[J].中华消化外科杂志,2014,13(1):39-41.

[8]CHENG J,XIANG HP,LI H.Surgery for severe acute biliary pancreatitis:clinical analysis of 20 cases and literature review[J].Anhui Med Pharm J,2012,16(2):202-204.(in Chinese)程俊,项和平,李贺.20例急性胆源性重症胰腺炎手术治疗体会并文献复习[J].安徽医药,2012,16(2):202-204.

[9]CHENG GH,YU CH,ZHANG YJ.Clinical research on severe acute pancreatitis complicated by acute respiratory distress syndrome[J].Chin J Prim Med Pharm,2012,19(15):2295-2296.(in Chinese)韩桂华,遇常红,张亚娟.重症急性胰腺炎并发急性呼吸窘迫综合征临床研究[J].中国基层医药,2012,19(15):2295-2296.

[10]WANG CY.Optimal timing and rational procedure of surgical intervention for severe acute pancreatitis[J].Chin J Digest Surg,2012,11(4):309-311.(in Chinese)王春友.重症急性胰腺炎外科干预的时机与方式[J].中华消化外科杂志,2012,11(4):309-311.

[11]CAO LJ.Correlation of change in platelet counts with prognosis in patients with acute pancreatitis[J].Anhui Med Pharm J,2012,16(5):624-625.(in Chinese)曹利军.重症胰腺炎血小板计数的动态变化与预后的关系[J].安徽医药,2012,16(5):624-625.

[12]SUN B,JIA G.Controversy and consensus of the therapy for severe acute pancreatitis[J].Chin J Digest Surg,2012,11(4):314-317.(in Chinese)孙备,贾光.重症急性胰腺炎治疗的争议与共识[J].中华消化外科杂志,2012,11(4):314-317.

[13]XIAO WM,LIU GL.The clinical effect on minimally invasive surgical treatment with per-pancreat region for severve acute pancreatitis[J].China Modern Med,2013,20(1):39-40.(in Chinese)肖文明,刘国利.围胰腺区域性微创治疗重症急性胰腺炎的临床效果观察[J].中国当代医药,2013,20(1):39-40.

[14]CHEN MF,WANG FM.Advances in severe acute pancreatitis treatments[J].J Clin Hepatol,2012,28(8):571-573.(in Chinese)陈梅福,王方明.重症急性胰腺炎治疗的进展[J].临床肝胆病杂志,2012,28(8):571-573.

[15]PENG Z.The timing of surgical intervention to acute hemorrhagic necrotizing pancreatitis and prognostic analysis[J].Mod Med Health,2014,30(2):194-195.(in Chinese)彭志.急性出血性坏死性胰腺炎外科干预时机与预后分析[J].现代医药卫生,2014,30(2):194-195.

[16]ZHANG C,YANG YL,LIN MJ,et al.Thoughts on the diagnosis and treatment of acute biliary pancreatitis[J].J Hepatopancreatobiliary Surg,2012,24(2):169-171.(in Chinese)张诚,杨玉龙,林美举,等.急性胆源性胰腺炎诊治的几点思考[J].肝胆胰外科杂志,2012,24(2):169-171.

[17]CAO J,GAN Q.Therapeutic effect of peri-pancreatic stepwise minimally invasive treatment in patients with severe acute pancreatitis:an analysis of 55 cases[J].Modern Diagn Treat,2013,24(17):3987-3988.(in Chinese)曹健,淦勤.围胰腺区域分步微创治疗55例重症急性胰腺炎疗效观察[J].现代诊断与治疗,2013,24(17):3987-3988.

Relative Articles

[1]	Weijia LI, Zhenfang LI, Qian ZHANG, Cong LI, Fengjiao WANG, Qi ZHAO. The association between gallstone and biliary pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(10): 2116-2120. doi: 10.12449/JCH241031
[2]	Wei ZHANG, Song ZHAI, Hong DU, Fuchun JING, Limei WANG, Ye ZHANG, Bibo KANG, Jiuping WANG, Shuangsuo DANG, Jianqi LIAN, Hong JIANG. Efficacy and safety of the 12-week sofosbuvir-coblopasvir regimen in treatment of chronic hepatitis C[J]. Journal of Clinical Hepatology, 2023, 39(3): 539-545. doi: 10.3969/j.issn.1001-5256.2023.03.009
[3]	Chan LI, Zhihai LIANG, Guodu TANG. Influencing factors for persistent inflammation, immunosuppression, and catabolism syndrome in patients with severe acute pancreatitis and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2023, 39(6): 1382-1390. doi: 10.3969/j.issn.1001-5256.2023.06.019
[4]	Zhangpeng WANG, Guangxu JING, Huanhuan LUO, Hongfei DONG, Xuyang WANG, Hongyu SUN, Lijun TANG. Efficacy and safety of aggressive fluid resuscitation versus conventional fluid resuscitation in early treatment of acute pancreatitis： A Meta－analysis[J]. Journal of Clinical Hepatology, 2023, 39(9): 2158-2168. doi: 10.3969/j.issn.1001-5256.2023.09.019
[5]	Ling QING, Weiqiang HUANG, Xiaohe LI, Feng CHEN, Yingxia LIU. Efficacy of antiviral therapy for chronic hepatitis B with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(9): 2075-2080. doi: 10.3969/j.issn.1001-5256.2021.09.015
[6]	Li Wei, Kang Yi, Ding GangQiang, Shang Jia, Zhou YuanPing. Clinical effect and safety of sofosbuvir-ledipasvir regimen in treatment of patients with HCV genotype 6a chronic hepatitis C[J]. Journal of Clinical Hepatology, 2019, 35(3): 526-529. doi: 10.3969/j.issn.1001-5256.2019.03.015
[7]	Chen RuFu, Zhong ChengRui, Zhou QuanBo. Current status and perspectives of minimally invasive surgical treatment of pancreatic head carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(5): 953-957. doi: 10.3969/j.issn.1001-5256.2019.05.004
[8]	Xi GuangLi, Dong Hao. Clinical effect of laparoscopic cholecystectomy and prognostic analysis in patients with acute cholecystitis[J]. Journal of Clinical Hepatology, 2018, 34(2): 332-336. doi: 10.3969/j.issn.1001-5256.2018.02.022
[9]	Ye HaiWen, Deng Yong, Zhang LingQiang, Wang HaiJiu, Zhou Ying, Xu XiaoLei, Fan HaiNing. Influence of HBV DNA load on surgical outcome of hepatitis B-associated liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(9): 1995-1998. doi: 10.3969/j.issn.1001-5256.2018.09.035
[10]	Huang Jie, Ren ShiPu, Yang LiWen. Clinical effect of ultrasound- guided percutaneous transhepatic gallbladder drainage in treatment of acute cholecystitis[J]. Journal of Clinical Hepatology, 2017, 33(2): 286-288. doi: 10.3969/j.issn.1001-5256.2017.02.016
[11]	Ning HuiMing, Ou Qiang, Huang Ling, Tang Qun. Clinical effect of Kezhi capsules in treatment of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2017, 33(1): 137-140. doi: 10.3969/j.issn.1001-5256.2017.01.030
[12]	Tan ZhanHai, Zhu GuangHui, Chen JianRong, Zhou LianMing, Yang Zhi, Zhang JiFa, Zhang XueLi, Dan YuanZhou. Clinical effect of laparoscopic cholecystectomy combined with laparoscopic choledocholithotomy T-tube drainage in treatment of gallbladder and common bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(5): 883-887. doi: 10.3969/j.issn.1001-5256.2017.05.018
[13]	Wu DongDong, Yang XiaoYan, Gao Feng. Research advances in minimally invasive treatment of infectious pancreatic necrosis[J]. Journal of Clinical Hepatology, 2017, 33(4): 785-789. doi: 10.3969/j.issn.1001-5256.2017.04.042
[14]	Tian Xing, Chen YanZhen, Chen ChengLiang, Jiao Jian. Advances in pathogenesis and minimally invasive therapies for extrahepatic portal biliopathy[J]. Journal of Clinical Hepatology, 2017, 33(6): 1192-1195. doi: 10.3969/j.issn.1001-5256.2017.06.038
[15]	Zhang Yong, Zeng WeiZheng, Wang YunXia, Weng Min, Zheng ShuMei, Jiang MingDe. Effect of continuous blood purification in treatment of patients with severe acute pancreatitis and multiple organ dysfunction syndrome[J]. Journal of Clinical Hepatology, 2016, 32(2): 320-323. doi: 10.3969/j.issn.1001-5256.2016.02.025
[16]	Liu Chao, Zhang Lei. Clinical efficacy of transumbilical single-port laparoscopic cholecystectomy in treatment of acute cholecystitis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1678-1681. doi: 10.3969/j.issn.1001-5256.2015.10.029
[17]	Zhang YiXi, Qiao Xin, Liu Bin, Qiao ShiXing. Application of minimally invasive technique in surgical treatment of pancreatic diseases[J]. Journal of Clinical Hepatology, 2015, 31(5): 681-683. doi: 10.3969/j.issn.1001-5256.2015.05.011
[18]	Liu LianLian, Xu Hui, Wang Hua, Liu Yang, Zou ZeFang, Yang Na. Clinical effect of endoscopic retrograde cholangiopancreatography in 80 elderly patients with biliary pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(8): 743-745. doi: 10.3969/j.issn.1001-5256.2014.08.011
[19]	Zhou SuMin, Gao PuJun. Advancement in the treatment of two subtypes of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2011, 27(11): 1219-1221.

Supplements(0)

Cited By

Cited by

Periodical cited type(8)

1.	赵彦，刘俐，吕辰艳，任田. 重症胰腺炎患者预后生存情况及与其临床特征的相关性研究. 解放军医药杂志. 2020(05): 78-81+98 .
2.	才仁卓玛，李兰英，逯金海，马登云，梁文倩. 探讨高原重症急性胰腺炎胰腺的症理改变特点及与临床的联系. 世界最新医学信息文摘. 2019(14): 31-32 .
3.	李国栋，陈元清. 经皮肾镜治疗重症急性胰腺炎感染性胰腺坏死的研究进展. 广西医学. 2019(04): 492-494 .
4.	陈明，王旭林，邢人伟，兰勇，凌乙升. 早期微创手术治疗重症急性胰腺炎对免疫功能的影响及临床效果. 中国医刊. 2019(09): 962-965 .
5.	何清，王立为. 营养支持、生长抑素联合乌司他丁治疗重症急性胰腺炎疗效分析. 临床军医杂志. 2018(03): 248-250+254 .
6.	林洁，曾繁林，朱宏泉. 改善重症急性胰腺炎预后的相关研究. 医学信息. 2018(24): 157-158 .
7.	吴东东，杨小艳，高峰. 感染性胰腺坏死的微创治疗进展. 临床肝胆病杂志. 2017(04): 785-789 . 本站查看
8.	潘素华. 重症急性胰腺炎临床诊治研究进展. 医学理论与实践. 2016(22): 3052-3053+3058 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2138) PDF downloads(366)

Effect and prognosis of peri- pancreatic stepwise minimally invasive treatment in patients with severe acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2016.03.029